Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore.

Annals of the Academy of Medicine, Singapore - 30 Mar 2023

Kanesvaran Ravindran, Chia Puey Ling, Chiong Edmund, Chua Melvin Lee Kiang, Ngo Nye Thane, Ow Samuel, Sim Hong Gee, Tan Min-Han, Tay Kiang Hiong, Wong Alvin Seng Cheong, Wong Siew Wei, Tan Puay Hoon

Abstract excerpt

Introduction: There has been a rapid evolution in the treatment strategies for metastatic castration-resistant prostate cancer (mCRPC) following the identification of targetable mutations, making genetic testing essential for patient selection. Although several international guidelines recommend genetic testing for patients with mCRPC, there is a lack of locally endorsed clinical practice guidelines in Singapore....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Counseling
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Metastasis

Share to Patient Selection

Share to Prostatic Neoplasms, Castration-Resistant

Share to Singapore

Source

Identifiers

PMID: 38904491
DOI: 10.47102/annals-acadmedsg.2022372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore.PMID 38904491Read ↗

Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate CancerSemantic proximity Read ↗

Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in CanadaSemantic proximity Read ↗

Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTCSemantic proximity Read ↗

Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutionsSemantic proximity Read ↗

Guidelines for genetic testing in prostate cancer: a scoping review.Semantic proximity Read ↗

Genetically Informed Prostate Cancer Treatment for Metastatic Disease.Semantic proximity Read ↗

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.Semantic proximity Read ↗

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.Semantic proximity Read ↗

Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.Semantic proximity Read ↗

The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now.Semantic proximity Read ↗

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational studySemantic proximity Read ↗

Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in GermanySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.